Breast cancer is among the most common cancers worldwide – and among the deadliest. The need for more effective therapy options is addressed by a steady stream of promising new approaches, for example using ultrasound ablation or even changing the tumours' molecular makeup for enhanced treatment efficiency. We also cover the benefits of centralisation for digital pathology networks, new insights into immunosuppression after organ transplantation, and concerns about the environmental impact of medication. Enjoy browsing!
Article • Promising approach
Focused ultrasound ablation for treatment of breast tumours
Focused ultrasound (FUS) ablation is an emerging treatment for breast tumours. Its use was highlighted in an October webinar focused on emerging immunotherapy research and breast cancer.
 |
Sponsored • JVC Kenwood launched the i3 series five years agoEvolution in Monitor TechnologyFive years ago, JVC Kenwood redesigned its monitors from the ground up and launched the i3 Series - kicking off a success story. |
 |
Article • Centralised image library and archiveFrom regional to national: digital pathology network transformationTransforming a regional digital pathology network into a national programme across the UK has the potential to save the NHS around £100m a year. Such a network – one that sees a centralised digital pathology image library and archive, as opposed ... |
 |
News • Making tumours susceptible to chemoBreast cancer: target protein may hold key to therapy successA rare variant of a protein present in nearly all human cells may hold the key to improving the effectiveness of breast cancer treatment, according to University of Manchester research. |
 |
Sponsored • Radiology equipmentLatest technology meets solid technologyIn radiology, it is important to place patients safely and precisely. This works with the "GetUp®" holding system from Febromed. |
 |
News • Preventing EBV reactivationLiver transplantation: Finding the "sweet spot" of immuno-suppressionDutch physicians have developed a system to determine the right dose of immunosuppressive drugs for patients to receive a donor liver - to prevent the activation of the Epstein-Barr virus. |
 |
News • Potential of immunotherapy exploredSurgery first for colon cancer? Not so fast, says new studyImmunotherapy prior to surgery is surprisingly effective for patients with a certain type of colorectal cancer (dMMR/MSI-H CRC). These new study results contrast current treatment regimens. |
 |
News • Sustainability assessmentEU laws need to look at the environmental impact of pharmaceuticals, study findsCurrent EU regulation does not adequately consider the environmental emissions of pharmaceuticals in global manufacturing supply chains, a recent study from Finland concludes. |
You are receiving this email because you subscribed to our newsletter on healthcare-in-europe If you don’t want to receive this newsletter anymore, click here to unsubscribe. Keep up-to-date on the latest news from all hospital-related fields! Copyright © 2024 mgo fachverlage GmbH & Co. KG. E.-C.-Baumann-Straße 5, 95326 Kulmbach, Germany |
   |